|
1
|
Bundred NJ: Prognostic and predictive
factors in breast cancer. Cancer Treat Rev. 27:137–142. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hutterer GC, Stoeckigt C, Stojakovic T,
Jesche J, Eberhard K, Pummer K, Zigeuner R and Pichler M: Low
preoperative lymphocyte-monocyte ratio (LMR) represents a
potentially poor prognostic factor in nonmetastatic clear cell
renal cell carcinoma. UrolOncol. 32:1041–1048. 2014.
|
|
4
|
Li MX, Liu XM, Zhang XF, Zhang JF, Wang
WL, Zhu Y, Dong J, Cheng JW, Liu ZW, Ma L and Lv Y: Prognostic role
of neutrophil-to-lymphocyte ratio in colorectal cancer: A
systematic review and meta-analysis. Int J Cancer. 134:2403–2413.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiao WK, Chen D, Li SQ, Fu SJ, Peng BG and
Liang LJ: Prognostic significance of neutrophil-lymphocyte ratio in
hepatocellular carcinoma: A meta-analysis. BMC Cancer. 14:1172014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen J, Deng Q, Pan Y, He B, Ying H, Sun
H, Liu X and Wang S: Prognostic value of neutrophil-to-lymphocyte
ratio in breast cancer. FEBS Open Bio. 5:502–507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang X, Du P and Yang Y: The clinical use
of neutrophil-to-lymphocyte ratio in bladder cancer patients: A
systematic review and meta-analysis. Int J Clin Oncol. 22:817–825.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akinci Ozyurek B, Sahin Ozdemirel T,
Buyukyaylaci Ozden S, Erdogan Y, Kaplan B and Kaplan T: Prognostic
value of the neutrophil to lymphocyte ratio (NLR) in lung cancer
cases. Asian Pac J Cancer Prev. 18:1417–1421. 2017.PubMed/NCBI
|
|
9
|
Asaoka T, Miyamoto A, Maeda S, Tsujie M,
Hama N, Yamamoto K, Miyake M, Haraguchi N, Nishikawa K, Hirao M, et
al: Prognostic impact of preoperative NLR and CA19-9 in pancreatic
cancer. Pancreatology. 16:434–440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao J, Zhu X, Zhao X, Li XF and Xu R:
Neutrophil-to-lymphocyte ratio predicts PSA response and prognosis
in prostate cancer: A systematic review and meta-analysis. PLoS
One. 11:e01587702016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Semeniuk-Wojtaś A, Lubas A, Stec R, Syryło
T, Niemczyk S and Szczylik C: Neutrophil-to-lymphocyte ratio,
platelet-to-lymphocyte ratio and C-reactive protein as new and
simple prognostic factors in patients with metastatic renal cell
cancer treated with tyrosine kinase inhibitors: A systemic review
and meta-analysis. Clin Genitourin Cancer. 16:e685–e693. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu K, Lou L, Ye J and Zhang S: Prognostic
role of the neutrophil-lymphocyte ratio in renal cell carcinoma: A
meta-analysis. BMJ Open. 5:e0064042015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park YH, Ku JH, Kwak C and Kim HH:
Post-treatment neutrophil-to-lymphocyte ratio in predicting
prognosis in patients with metastatic clear cell renal cell
carcinoma receiving sunitinib as first line therapy. Springerplus.
3:2432014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang
J, Wang T, Zhu W and Liu P: Prognostic value of PLR in various
cancers: A meta-analysis. PLoS One. 9:e1011192014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu Z and Xu W, Cheng H, Shen W, Ying J,
Cheng F and Xu W: The prognostic role of the platelet-lymphocytes
ratio in gastric cancer: A meta-analysis. PLoS One.
11:e01637192016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan D, Fu Y, Su Q and Wang H: Prognostic
role of platelet-lymphocyte ratio in colorectal cancer: A
systematic review and meta-analysis. Medicine (Baltimore).
95:e38372016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Y, Si G, Zhu F, Hui J, Cai S, Huang
C, Cheng S, Fathy AH, Xiang Y and Li J: Prognostic role of platelet
to lymphocyte ratio in hepatocellular carcinoma: A systematic
review and meta-analysis. Oncotarget. 8:22854–22862. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Raungkaewmanee S, Tangjitgamol S,
Manusirivithaya S, Srijaipracharoen S and Thavaramara T: Platelet
to lymphocyte ratio as a prognostic factor for epithelial ovarian
cancer. J Gynecol Oncol. 23:265–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi F, Gu Y, Chen S, Liu Y, Yin W, Zhang Y
and Cao B: Impact of the pretreatment or posttreatment NLR and PLR
on the response of first line chemotherapy and the outcomes in
patients with advanced non-small cell lung cancer. Zhongguo Fei Ai
Za Zhi. 21:481–492. 2018.(In Chinese). PubMed/NCBI
|
|
20
|
Zhou Y, Cheng S, Fathy AH, Qian H and Zhao
Y: Prognostic value of platelet-to-lymphocyte ratio in pancreatic
cancer: A comprehensive meta-analysis of 17 cohort studies. Onco
Targets Ther. 5:1899–1908. 2018. View Article : Google Scholar
|
|
21
|
Wang J, Liu Y, Zhang N, Li X, Xin P, Bi J
and Kong Ch: Prognostic role of pretreatment platelet to lymphocyte
ratio in urologic cancer. Oncotarget. 8:70874–70882.
2017.PubMed/NCBI
|
|
22
|
Sciarra A, Gentilucci A, Salciccia S,
Pierella F, Del Bianco F, Gentile V, Silvestri I and Cattarino S:
Prognostic value of inflammation in prostate cancer progression and
response to therapeutic: A critical review. J Inflamm (Lond).
13:352016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gunduz S, Mutlu H, Tural D, Yıldız Ö,
Uysal M, Coskun HS and Bozcuk H: Platelet to lymphocyte ratio as a
new prognostic for patients with metastatic renal cell cancer. Asia
Pac J Clin Oncol. 11:288–292. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Park TJ, Cho YH, Chung HS, Hwang EC, Jung
SH, Hwang JE, Bae WK, Kim JW, Heo SH, Hur YH, et al: Prognostic
significance of platelet-lymphocyte ratio in patients receiving
first-line tyrosine kinase inhibitors for metastatic renal cell
cancer. Springerplus. 5:18892016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Minami S, Ihara S and Komuta K:
Pretreatment lymphocyte to monocyte ratio as a prognostic marker
for advanced pulmonary squamous cell carcinoma treated with
chemotherapy. J Clin Med Res. 10:657–664. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang YT, Jiang JH, Yang HJ, Wu ZJ, Xiao ZM
and Xiang BD: The lymphocyte-to-monocyte ratio is a superior
predictor of overall survival compared to established biomarkers in
HCC patients undergoing liver resection. Sci Rep. 8:25352018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu Q, Hu T, Zheng E, Deng X and Wang Z:
Prognostic role of the lymphocyte-to-monocyte ratio in colorectal
cancer: An up-to-date meta-analysis. Medicine (Baltimore).
96:e70512017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kimyon Cömert G, Türkmen O, Kar İ, Sınacı
S, Yılmaz Ergani S, Karalök A, Başaran D and Turan T: Independent
predictors of survival in endometrium cancer:
Platelet-to-lymphocyte ratio and
platelet/neutrophil/monocyte-to-lymphocyte ratio. J Turk Ger
Gynecol Assoc. 19:78–86. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li W, Tao L, Zhang L and Xiu D: Prognostic
role of lymphocyte to monocyte ratio for patients with pancreatic
cancer: A systematic review and meta-analysis. Onco Targets Ther.
10:3391–3397. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma JY and Liu Q: Clinicopathological and
prognostic significance of lymphocyte to monocyte ratio in patients
with gastric cancer: A meta-analysis. Int J Surg. 50:67–71. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiang J, Zhou L, Li X, Bao W, Chen T, Xi
X, He Y and Wan X: Preoperative monocyte-to-lymphocyte ratio in
peripheral blood predicts stages, metastasis, and histological
grades in patients with ovarian cancer. Transl Oncol. 10:33–39.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ni XJ, Zhang XL, Ou-Yang QW, Qian GW, Wang
L, Chen S, Jiang YZ, Zuo WJ, Wu J, Hu X, et al: An elevated
peripheral blood lymphocyte-to-monocyte ratio predicts favorable
response and prognosis in locally advanced breast cancer following
neoadjuvant chemotherapy. PLoS One. 9:e1118862014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu RJ, Liu Q, Ma JY, Zhou J and Liu G:
Preoperative lymphocyte-to-monocyte ratio predicts breast cancer
outcome: A meta-analysis. Clin Chim Acta. 84:1–6. 2018. View Article : Google Scholar
|
|
34
|
Jia W, Wu J, Jia H, Yang Y, Zhang X, Chen
K and Su F: The peripheral blood neutrophil-to-lymphocyte ratio is
superior to the lymphocyte-to-monocyte ratio for predicting the
long-term survival of triple-negative breast cancer patients. PLoS
One. 10:e01430612015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu Y, Si W, Sun Q, Qin B, Zhao W and Yang
J: Platelet-lymphocyte ratio acts as an indicator of poor prognosis
in patients with breast cancer. Oncotarget. 8:1023–1030.
2017.PubMed/NCBI
|
|
36
|
West HJ and Jin JO: Performance status in
patients with cancer. JAMA Oncol. 1:9982015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li J, Chen Q, Luo X, Hong J, Pan K, Lin X,
Liu X, Zhou L, Wang H, Xu Y, et al: Neutrophil-to-lymphocyte ratio
positively correlates to age in healthy population. J Clin Lab
Anal. 29:437–443. 2015. View Article : Google Scholar : PubMed/NCBI
|
